Edinburgh, Scotland (September 3rd, 2024) - Blackford, the pioneering strategic AI platform and solutions provider, and Coreline, a leading provider of AI solutions for lung cancer screening, today announced a commercial partnership to bring Coreline’s AVIEW solutions for thoracic CT to healthcare professionals via the Blackford Platform.
Blackford provides healthcare professionals with consultative support and access to an extensive portfolio of more than 135 AI solutions designed to drive clinical accuracy and efficiency and improve patient outcomes. Integrating Coreline's comprehensive technology into the Blackford Platform equips healthcare providers with potent tools for detecting thoracic diseases.
"Coreline’s comprehensive solutions for lung and cardiac health are a great addition to our portfolio" says Ben Panter, Founder and CEO of Blackford. "This partnership amplifies our ability to deliver innovative technologies to healthcare professionals to enhance diagnostics and prevention of diseases such as lung cancer and COPD."
The impact of Coreline's AVIEW solutions is demonstrated through numerous case studies, confirming the technology’s ability to accurately detect diseases in their early stages*. Coreline's extensive diagnostic experience in the healthcare industry, combined with its involvement in nationwide healthcare projects, is aimed to play a crucial role in enhancing overall patient outcomes.
AVIEW LCS specializes in identifying and assessing pulmonary nodules, aiding radiologists in recognizing the nodules in the early stages, when lung cancer is still treatable.
AVIEW COPD provides insights on LAA, HAA analysis to support radiologists to easily detect and classify emphysema and airway wall thickness, blood vessels and fissure completeness to help clinicians gain a deeper understanding of COPD progression.
AVIEW CAC provides accurate scoring of calcium deposits, allowing for precise risk stratification and aids preventive healthcare measures.
The above solutions are available in a bundle called AVIEW LCS Plus is one of the very few solutions currently on the market that provides comprehensive analysis of the "Big 3" diseases: lung nodules (LCS), LAA analysis to identify COPD, and coronary artery calcification (CAC) from a single scan. This offers clinicians valuable insights not only into suspected conditions but also potential high-risk lung cancer comorbidities.
AVIEW Lung Texture evaluates interstitial lung diseases (ILD) by analyzing various lung textures in CT scans. It detects patterns like ground-glass opacities, reticulation, and honeycombing, emphysema and consolidation, and provides a comprehensive and automated assessment that aids clinicians in early detection and classification. **
“Partnering with Blackford Analysis is a significant step forward in our mission to transform diagnostic imaging,” said Jason Suh, Overseas Business Director of Coreline. “Blackford’s extensive experience in healthcare software perfectly aligns with our vision of delivering advanced, AI-enhanced imaging solutions that help clinicians make informed and evidence-based decisions faster.”
Together, this partnership will further empower healthcare organizations and professionals to utilize AI to improve diagnosis, optimize workflows, and ultimately provide better care to patients worldwide.